Pharma Reaserch Prod Stock EBITDA
| 214450 Stock | KRW 251,000 500.00 0.20% |
Pharma Reaserch Prod fundamentals help investors to digest information that contributes to Pharma Reaserch's financial success or failures. It also enables traders to predict the movement of Pharma Stock. The fundamental analysis module provides a way to measure Pharma Reaserch's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharma Reaserch stock.
Pharma |
Pharma Reaserch Prod Company EBITDA Analysis
Pharma Reaserch's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
According to the company disclosure, Pharma Reaserch Prod reported earnings before interest,tax, depreciation and amortization of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as EBITDA (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Pharma EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharma Reaserch's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharma Reaserch could also be used in its relative valuation, which is a method of valuing Pharma Reaserch by comparing valuation metrics of similar companies.Pharma Reaserch is currently under evaluation in ebitda category among its peers.
About Pharma Reaserch Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharma Reaserch Prod's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharma Reaserch using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharma Reaserch Prod based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Pharma Reaserch
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pharma Reaserch position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Reaserch will appreciate offsetting losses from the drop in the long position's value.Moving against Pharma Stock
| 0.69 | 373220 | LG Energy Solution | PairCorr |
| 0.63 | 051915 | LG Chem | PairCorr |
| 0.56 | 051910 | LG Chemicals | PairCorr |
| 0.44 | 005935 | Samsung Electronics | PairCorr |
| 0.4 | 005387 | Hyundai Motor | PairCorr |
The ability to find closely correlated positions to Pharma Reaserch could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharma Reaserch when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharma Reaserch - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharma Reaserch Prod to buy it.
The correlation of Pharma Reaserch is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pharma Reaserch moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pharma Reaserch Prod moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pharma Reaserch can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Pharma Stock
Pharma Reaserch financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Reaserch security.